COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?

The authors present the data on the potential of the combination of angiotensin-converting enzyme inhibitors and calcium channel antagonists in the treatment of hypertensive patients with chronic heart failure and preserved left ventricular ejection fraction. The informed choice of lisinopril, as a...

Full description

Bibliographic Details
Main Authors:	I. V. Zhirov, O. A. Nikolaeva, S. N. Tereshchenko
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2013-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ингибитор ангиотензин-превращающего фермента амлодипин лизиноприл хроническая сердечная недостаточность с сохраненной систолической функцией левого желудочка
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/97

Similar Items

Modern concept of diastolic heart failure
by: F. T. Ageev
Published: (1970-01-01)

Levels of cytokines and C-reactive protein as treatment effectiveness criteria in patients with coronary heart disease and chronic heart failure
by: E. Yu. Sazhina, et al.
Published: (2008-06-01)

Atorvastain effectiveness in patients with heart failure, preserved systolic function, and paroxysmal atrial fibrillation
by: E. S. Kozlova, et al.
Published: (2009-12-01)

Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)

PRESTIGE study: ACE inhibitors efficacy in patients with acute myocardial infarction and left ventricular dysfunction
by: Yu. N. Belenkov, et al.
Published: (2005-04-01)

Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction
by: O. M. Drapkina, et al.
Published: (2020-04-01)

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization
by: Yu. V. Mareev, et al.
Published: (2023-01-01)

Treatment of chronic heart failure with a very low dose of antibodies to C-fragment of type 1 angiotensin II receptor
by: T. M. Poponina, et al.
Published: (2009-08-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

Cardiac Amyloidosis: Internist and Cardiologist Insight
by: E. V. Reznik, et al.
Published: (2020-12-01)

Dynamics of the main parameters of structure-functional condition of the left ventricle myocardium in usage of combination antihypertension therapy for postmenopausal women with different obesity patterns
by: V. V. Skibitsky, et al.
Published: (2016-04-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW
by: S. R. Gilyarevskiy, et al.
Published: (2016-01-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

Atrial Fibrillation and Heart Failure as the Onset of AL-Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-11-01)

Fixed-dose combination of perindopril and indapamide: perspectives in hypertensive patients with inadequately controlled blood pressure
by: I. E. Chazova, et al.
Published: (2007-02-01)

APPLICATION OF NEW ECHOCARDIOGRAPHIC TECHNOLOGIES OF NON-DOPPLER MYOCARDIAL IMAGES IN 2D AND 3D MODES IN PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION
by: V. Kh. Sohibnazarova, et al.
Published: (2017-06-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Predictive criteria for the function of the right ventricle of the heart during mechanical bypass of the left ventricle
by: D. D. Uzunin, et al.
Published: (2021-12-01)

Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older
by: V. N. Larina, et al.
Published: (2020-11-01)

Left ventricular structure and function in chronic renal disease
by: V. V. Skibitsky, et al.
Published: (2009-12-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

Calcium-Phosphate Nanoparticles — a System for Drug Delivery to the Anterior Eye Chamber
by: O. V. Beznos, et al.
Published: (2021-07-01)

COMBINATION ANTIHYPERTENSIVE THERAPY: WHEN THE WHOLE IS GREATER THAN THE SUM OF ITS PARTS
by: E. O. Taratukhin, et al.
Published: (2013-06-01)

NON-COMPACTION MYOCARDIUM OF THE LEFT VENTRICLE: SECONDARY PREVENTION OF THROMBOEMBOLISM
by: R. P. Myasnikov, et al.
Published: (2017-02-01)

EVALUATION OF DEFORMATION OF THE LEFT VENTRICLE AND LEFT ATRIUM, AND THE ROTATIONAL PROPERTIES OF THE LEFT VENTRICLE IN PATIENTS WITH CHF ACCORDING TO THE ECHOCARDIOGRAPHIC TECHNOLOGY OF NON-DOPPLER IMAGING IN TWO AND THREE-DIMENSIONAL REGIMENS
by: V. K. Sohibnazarova, et al.
Published: (2018-06-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

Trimetazidine effects on heart and kidney functional status, and quality of life in long-term complex treatment of chronic heart failure in elderly patients
by: M. E. Statsenko, et al.
Published: (2005-10-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)

Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
by: T. V. Aparina, et al.
Published: (2005-06-01)

The Value of Biomarkers in the Diagnosis and Prognosis of Heart Failure in Older Age
by: V. N. Larina, et al.
Published: (2021-03-01)

Growth Differentiation Factor-15 (GDF-15) is a Biological Marker in Heart Failure
by: A. M. Alieva, et al.
Published: (2023-01-01)

The relationship between gut microbiota, chronic systemic inflammation, and endotoxemia in patients with heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2022-10-01)

In the wake of the latest clinical guidelines - mineralocorticoid receptor antagonists in the treatment of chronic heart failure
by: I. V. Zhirov, et al.
Published: (2015-12-01)

THE SPECIFICS OF NONCOMPACTED CARDIOMYOPATHY MANIFESTATION
by: R. P. Myasnikov, et al.
Published: (2015-10-01)

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)